Journal of Lipid Research, Vol 33, 1099-1110, Copyright © 1992 by Lipid Research, Inc.

REVIEWS

Molecular basis of mitochondrial fatty acid oxidation defects

PM Coates and K Tanaka
Division of Gastroenterology, Nutrition, and Lipid-Heart Research, Children's Hospital of Philadelphia, PA 19104.

A dozen separate inherited disorders of mitochondrial fatty acid beta- oxidation have been described in humans. This represents about half of the potential sites for genetic error that can affect this important pathway of energy metabolism. As the characterization of these disorders at the clinical and biochemical levels has progressed rapidly, so has the delineation of the molecular defects that underlie them. The most commonly recognized disorder of beta-oxidation is medium- chain acyl-CoA dehydrogenase deficiency; a striking feature of this disorder is that there is a single point mutation that accounts for 90% of the variant alleles among patients with medium-chain acyl-CoA dehydrogenase deficiency. Molecular defects of other enzymes in the pathway have been identified, and it seems likely that a complete description of these defects at the molecular level is a realistic goal. In basic biological terms, such studies will lead to a better understanding of the genetic control exerted on this pathway. In clinical terms, they will lead to improved understanding of the molecular pathophysiology of these diseases and may well provide the necessary techniques to proceed with the screening of these disorders.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. Wan and R. W. Hubbard Determination of free and total carnitine with a random-access chemistry analyzer Clin. Chem., April 1, 1998; 44(4): 810 - 816. [Abstract] [Full Text] [PDF]